These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6438518)

  • 1. Treatment Outcome Prospective Study (TOPS): client characteristics and behaviors before, during, and after treatment.
    Hubbard RL; Rachal JV; Craddock SG; Cavanaugh ER
    NIDA Res Monogr; 1984; 51():42-68. PubMed ID: 6438518
    [No Abstract]   [Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of substance-abusing women on welfare. Findings from the evaluation of CASAWORKS for Families pilot demonstration.
    Gutman MA; Ketterlinus RD; McLellan AT
    Eval Rev; 2003 Dec; 27(6):597-628. PubMed ID: 14650277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIS-based client outcome evaluation: a multi-measure approach.
    Volkert JJ
    Addict Dis; 1979; 3(4):491-504. PubMed ID: 262072
    [No Abstract]   [Full Text] [Related]  

  • 7. Privacy Act; notification of a new system of records. Public Health Service. Notification of a new system of records: 09-30-0039, "Drug Abuse Treatment Outcome Prospective Study (TOPS)".
    Fed Regist; 1982 Jan; 47(11):2508-10. PubMed ID: 10317167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for evaluation of drug dependency treatment based on data provided by a management information system.
    Sells SB; Simpson DD
    Addict Dis; 1979; 3(4):533-54. PubMed ID: 262073
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment services received in the CASAWORKS for Families program.
    McKay JR; Gutman M; McLellan AT; Lynch KG; Ketterlinus R
    Eval Rev; 2003 Dec; 27(6):629-55. PubMed ID: 14650278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAMHSA releases revised and updated treatment improvement protocol on co-occurring disorders.
    Psychiatr Serv; 2005 Mar; 56(3):371. PubMed ID: 15816109
    [No Abstract]   [Full Text] [Related]  

  • 11. Similarities in outcomes for men and women after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS).
    Stewart D; Gossop M; Marsden J; Kidd T; Treacy S
    Drug Alcohol Rev; 2003 Mar; 22(1):35-41. PubMed ID: 12745357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to the process of seeking and completing treatment for drug abuse (qualitative methods in drug abuse research).
    Otiashvili D; Djordjevic A; Morales D; Parsons A; Platt E; Stempliuk V
    Georgian Med News; 2005 May; (122):29-32. PubMed ID: 15988078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a client-centered understanding of drug treatment.
    McGowan K; Sorge R
    Health PAC Bull; 1993; 23(3):4-8, 11-5. PubMed ID: 10171778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early identification and prevention of mental retardation.
    Persha AJ
    ICCW News Bull; 1992; 40(1):9-12. PubMed ID: 12344890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes.
    Chi FW; Satre DD; Weisner C
    Alcohol Clin Exp Res; 2006 May; 30(5):851-9. PubMed ID: 16634854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women.
    Howard J; Beckwith L
    NIDA Res Monogr; 1996; 166():68-86. PubMed ID: 8818166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of mental health parity and managed care in one large employer group: a reexamination.
    Zuvekas SH; Rupp AE; Norquist GS
    Health Aff (Millwood); 2005; 24(6):1668-71. PubMed ID: 16284042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.